The Bland Company

The Bland Company is a London-based food technology startup developing a proprietary biochemical processing platform that converts agricultural side streams — including byproducts from rice and pasta production — into high-performance functional proteins capable of replacing eggs in industrial food manufacturing. The company's platform is feedstock-agnostic, meaning it can adapt to different abundant plant inputs without requiring novel manufacturing equipment, and is designed to plug directly into existing food production infrastructure as a drop-in ingredient solution.

Eggs are deeply embedded in modern food manufacturing — roughly one third of global egg production flows into industrial applications including baked goods, sauces, confectionery, and prepared foods. Despite their ubiquity, eggs present a persistent procurement challenge: prices have swung two to three times over the past 18 months, driven by avian flu outbreaks, cage-free regulation rollouts, climate-related feed cost pressures, and seasonal demand shifts. Existing plant-based alternatives have either lacked functional performance or come at a price point that blocks significant scale. The Bland Company was founded on the conviction that a new class of functional proteins, built from overlooked agricultural side streams, could achieve both performance parity and cost efficiency simultaneously.

The platform produces proteins with enhanced solubility, foaming, binding, and emulsification properties — matching or exceeding egg-white performance benchmarks. Early pilot trials with large consumer packaged goods companies in the US and Europe have demonstrated three-to-four-times improvements in solubility, alongside significant gains in foaming and emulsification performance. The company's beachhead applications are baked goods, condiments, and confectionery, where egg performance and cost predictability are critical to large-scale production.

The Bland Company was founded in 2024 and raised £2 million in a pre-seed round in February 2026 led by Initialized Capital, with participation from Entrepreneurs First, Alumni Ventures, Transpose Platform, Behind Genius Ventures, and Vento. The founders met at the Entrepreneur First accelerator in London. The funding will be used to hire scientists and engineers to advance protein chemistry and application science capabilities.